Related Experiment Videos
Percutaneous dilation tracheostomy during high-frequency oscillatory ventilation
1Critical Care Directorate, Cardiff and Vale NHS Trust, University Hospital of Wales, Cardiff, UK.
Critical Care Medicine
|August 7, 2002
Summary
Percutaneous dilational tracheostomy is safe for patients with acute respiratory distress syndrome (ARDS) on high-frequency oscillatory ventilation (HFOV). This procedure maintained stable hemodynamics and respiratory function without complications.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Surgical Procedures
Background:
- Acute respiratory distress syndrome (ARDS) often requires mechanical ventilation, including high-frequency oscillatory ventilation (HFOV).
- Tracheostomy is a common procedure for prolonged mechanical ventilation, but its safety during HFOV is less established.
- Percutaneous dilational tracheostomy (PDT) offers a minimally invasive approach.
Observation:
- A case series evaluated the feasibility and safety of PDT in five ARDS patients undergoing HFOV.
- Hemodynamic and respiratory parameters were monitored throughout the PDT procedure.
- No procedure-related complications were observed.
Findings:
- PDT was successfully and safely performed in all five ARDS patients on HFOV.
- The procedure did not lead to significant hemodynamic or respiratory instability.
- No adverse events were attributed to PDT or concurrent HFOV.
Implications:
- PDT is a viable and safe option for tracheostomy in ARDS patients requiring HFOV.
- This finding supports the use of PDT in complex ventilated patients.
- Further research may explore broader application and long-term outcomes.